scholarly journals Mechanochemical Endovenous Ablation of Small Saphenous Vein Insufficiency Using the ClariVein® Device: One-year Results of a Prospective Series

2013 ◽  
Vol 45 (3) ◽  
pp. 299-303 ◽  
Author(s):  
D. Boersma ◽  
R.R.J.P. van Eekeren ◽  
D.A.B. Werson ◽  
R.I.F. van der Waal ◽  
M.M.J.P. Reijnen ◽  
...  
Vascular ◽  
2014 ◽  
Vol 23 (6) ◽  
pp. 592-598 ◽  
Author(s):  
Stavros Spiliopoulos ◽  
Vasiliki Theodosiadou ◽  
Athanasia Sotiriadi ◽  
Dimitrios Karnabatidis

This is a prospective trial investigating endovenous radiofrequency ablation with the EVRF® system for the treatment of symptomatic varicose veins. Primary endpoints include one-year anatomical and clinical success and procedure-related complications. Secondary endpoints include adjunctive procedures and recanalization rates, periprocedural pain assessment, and time return to normal activities. In 60 patients with 74 limbs, 58 great saphenous vein, 11 small saphenous vein, 2 anterior accessory saphenous vein, and 3 perforators were ablated. Additional ablations for further improvement were necessary in 28.4%. Clinical success was 94.6%. Anatomical success was 96.0% at one month and 89.2% at one year. Primary ablation success was 77%. Revascularization occurred in 12.1%. Clinically driven repeat ablation rate was 4.0%. Perforator ablation due to segmental revascularization was performed in 5.4%. Complications included one puncture-site infection, three scars, two cases of transient paresthesia, and one skin pigmentation. Periprocedural mean pain score was 2.4 ± 2.6. In 27.0% cases, the patients used analgesics and mean time return was 1.2 ± 0.5 days. The EVRF® system yields satisfactory clinical and anatomical midterm outcomes with very low complication rates.


2014 ◽  
Vol 23 (3) ◽  
pp. 176-179 ◽  
Author(s):  
Yücel ÖZEN ◽  
Davut ÇEKMECELİOĞLU ◽  
Sabit SARIKAYA ◽  
Murat Bülent RABUŞ ◽  
Ebuzer AYDIN ◽  
...  

2014 ◽  
Vol 21 (3) ◽  
pp. 429-433 ◽  
Author(s):  
Ramon R.J.P. van Eekeren ◽  
Jan Luuk Hillebrands ◽  
Kim van der Sloot ◽  
Jean-Paul P.M. de Vries ◽  
Clark J. Zeebregts ◽  
...  

2014 ◽  
Vol 2 (3) ◽  
pp. 282-288 ◽  
Author(s):  
Ramon R.J.P. van Eekeren ◽  
Doeke Boersma ◽  
Suzanne Holewijn ◽  
Debora A.B. Werson ◽  
Jean Paul P.M. de Vries ◽  
...  

2008 ◽  
Vol 48 (3) ◽  
pp. 675-679 ◽  
Author(s):  
Xinwu Lu ◽  
Kaichuang Ye ◽  
Weimin Li ◽  
Min Lu ◽  
Xintian Huang ◽  
...  

2013 ◽  
Vol 29 (10) ◽  
pp. 654-657 ◽  
Author(s):  
Leo P Sullivan ◽  
Giang Quach ◽  
Tina Chapman

Objective To present the use of retrograde mechanico-chemical endovenous ablation for ablating the remaining below-knee great saphenous vein in patients with venous stasis ulcers persisting after above-knee great saphenous vein ablation. Methods This small study includes six patients with persistent C6EpAsPr ulcers following above-knee great saphenous vein ablation with no incompetent perforators. They were treated using retrograde mechanico-chemical endovenous ablation approach followed by Unna therapy, followed up on post op days 3 and 30 with ultrasound, and subsequent weekly visits until the wound healed. Results Six patients (four men and two women), have average ulcer size of 4.1 cm2. There was no nerve injury or other complications after mechanico-chemical endovenous ablation. These patients had an average of 28 ± 11 days healing time, compared with a mean of five months in traditional method. Conclusion Mechanico-chemical endovenous ablation can be safe and effective in the treatment of patients with below-knee great saphenous vein insufficiency with venous ulcers.


Sign in / Sign up

Export Citation Format

Share Document